Resistant depression and Alzheimer's are diseases for which the current treatment is insufficient. Psychedelic mushrooms have been used in traditional medicine to treat mental and cognitive disorders and some specific psychedelic molecules have been studied in the past and are currently being studied for psychiatric disorders and other diseases. Our team is the first in Israel and one of the few in the world to receive official permission to grow and produce psilocybin mushrooms for research purposes. The purpose of the research, which received a budget of half a million NIS from the Bequest Committee, is to test the affinity and effect between the active substances in psilocybin mushrooms and the relevant receptors in the human body.
We wish them luck!